EUR/USD 1.1478 ▲ 0.12%GBP/USD 1.3379 ▼ 0.01%USD/JPY 155.6987 ▼ 0.40%USD/CHF 0.8255 ▼ 0.05%EUR/CHF 0.9458 ▼ 0.10%BTC/USD 76,414.92 ▲ 0.27%ETH/USD 2,444.3 ▲ 1.08%SOL/USD 99.68 ▲ 1.03%XAU/USD 4,303.15 ▲ 0.92%EUR/USD 1.1478 ▲ 0.12%GBP/USD 1.3379 ▼ 0.01%USD/JPY 155.6987 ▼ 0.40%USD/CHF 0.8255 ▼ 0.05%EUR/CHF 0.9458 ▼ 0.10%BTC/USD 76,414.92 ▲ 0.27%ETH/USD 2,444.3 ▲ 1.08%SOL/USD 99.68 ▲ 1.03%XAU/USD 4,303.15 ▲ 0.92%
Finance Review DailyMARKETS • BUSINESS • ECONOMY
BREAKING
Crude oil futures rise as Brent tops $100 amid Middle East conflict and Gulf supply worries•House panel advances bill to codify Trump’s Bitcoin reserve•US Stocks Retreat as Oil Hits $100; Meta Lifts Nasdaq•Morgan Stanley sees ECB 25 bps hike to 2.75% in Dec 2026•Crude oil futures rise as Brent tops $100 amid Middle East conflict and Gulf supply worries•House panel advances bill to codify Trump’s Bitcoin reserve•US Stocks Retreat as Oil Hits $100; Meta Lifts Nasdaq•Morgan Stanley sees ECB 25 bps hike to 2.75% in Dec 2026•
ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Business/EarningsArticle

Earnings call transcript: Galliford Try H2 2026 profit, cash and buyback lift shares

Finance Review Daily is tracking this developing story; further verified details were not immediately available.

PA
Priya Anand · Equities & Earnings Desk · 17 Sept 2026 · 22:53 · 1 min read
Share
Earnings call transcript: Galliford Try H2 2026 profit, cash and buyback lift shares

Earnings call transcript: Galliford Try H2 2026 profit, cash and buyback lift shares.

Finance Review Daily is tracking this development following a report from Investing.com – Earnings Call Transcripts. Finance Review Daily will provide updates as verified details become available.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT

Market Snapshot

Delayed
EUR/USD1.1478▲ 0.12%GBP/USD1.3379▼ 0.01%USD/CHF0.8255▼ 0.05%BTC/USD76,414.92▲ 0.27%ETH/USD2,444.3▲ 1.08%XAU/USD4,303.15▲ 0.92%

Related Reading

NeuroPace Touts Growth, Clinical Data, FDA Path at Cantor Conference
Earnings

NeuroPace Touts Growth, Clinical Data, FDA Path at Cantor Conference

Priya Anand · 4 min ago
ADVERTISEMENT